Furthermore, the inhibitory activity of human CD19+CD24hiIgDlo/−CD38lo and CD19+CD24hiIgDlo/−CD38hi Bregs from both healthy subjects and cancer patients was significantly reduced by treatment with GSK (Fig. 5d, e, left). Here, CD19 is linked to cancer.